|
|
Article: NeoPharm Investigators to Present New and Updated Clinical Data on Cintredekin Besudotox at the American Association of Neurological Surgeons Annual Meeting.
- Article from:
- Business Wire
- Article date:
- April 17, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NeoPharm, Inc. (NASDAQ/NM:NEOL):
Who/What: NeoPharm, Inc. (NASDAQ/NM:NEOL) clinical data
presentations on cintredekin besudotox ("IL13-PE38QQR")
Where: American Association of Neurological Surgeons (AANS) 2006
Annual Meeting
April 22-27, 2006
Moscone Convention Center
San Francisco, CA
When: Monday, April 24, 2006
Scientific Session I - Tumor
3:15pm - 3:30pm
Long-Term Follow-Up of Convection Enhanced Delivery of
Cintredekin Besudotox (IL13-PE38QQR): UCSF Experience from
Phase I Study.
Authors: Sandeep ...